SELLAS Life Sciences Group, Inc. (SLS) Tops Q3 EPS by 3c

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) reported Q3 EPS of ($0.10), $0.03 better than the analyst estimate of ($0.13).

For earnings history and earnings-related data on SELLAS Life Sciences Group, Inc. (SLS) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Immix Biopharma (IMMX) Reiterated at Market Outperform by Citizens on Upcoming Milestones
• JPMorgan Upgrades FOX Corp. (FOXA) to Overweight